McLaren’s New Health Care Campus Begins to Open
McLaren Health Care and Michigan State University held a ceremonial ribbon cutting to mark the opening of the $600 million health care campus adjacent to the university. The health care campus includes a 240-bed hospital, a multi-specialty outpatient care center and a Karmanos Cancer Institute in partnership with MSU Health Care.
“This new health care campus offers exciting facilities for MSU’s medical education, research and service to our regional community in collaboration with McLaren Health Care,” MSU President Samuel L. Stanley Jr., M.D., said. “Community partnerships are the basis of MSU’s medical education and health care delivery across Michigan. We look forward to continuing to work with McLaren as we pursue our vision for new models for sustainable health care.”
“This new health care campus offers exciting facilities for MSU’s medical education, research and service to our regional community in collaboration with McLaren Health Care,” MSU President Samuel L. Stanley Jr., M.D., said. “Community partnerships are the basis of MSU’s medical education and health care delivery across Michigan. We look forward to continuing to work with McLaren as we pursue our vision for new models for sustainable health care.”
One Year of Discovery and Collaboration: Henry Ford and MSU
When Henry Ford Health System and Michigan State University formally announced a 30-year partnership one year ago today, the organizations set themselves on a trajectory toward a bold vision – to discover and advance a new standard of health to transform life.
It is with that vision in mind that the two organizations mark their first anniversary by expressing gratitude to their respective teams.
It is with that vision in mind that the two organizations mark their first anniversary by expressing gratitude to their respective teams.
Spartans Are Engineering a Healthier Future
At Michigan State University, researchers are unlocking the power of genuine collaboration to drive discovery and create healthier tomorrows for all. Spartan engineers are partnering with biological and health scientists to develop innovative solutions to fight diseases and improve treatments.
“Engineers and biological scientists look at problems differently,” says Christina Chan, University Distinguished Professor, George W. Bissell Professor and interim chairperson of the Department of Chemical Engineering and Materials Science. “The advantage of having different perspectives is that then people come with different backgrounds, and that tends to engender a more creative approach to solving some of these research problems and questions that are raised.”
“Engineers and biological scientists look at problems differently,” says Christina Chan, University Distinguished Professor, George W. Bissell Professor and interim chairperson of the Department of Chemical Engineering and Materials Science. “The advantage of having different perspectives is that then people come with different backgrounds, and that tends to engender a more creative approach to solving some of these research problems and questions that are raised.”
Stress-Testing Physics at FRIB
It’s strange to think that there are nuclear reactions that physicists classify as gentle. After all, the particle accelerators that let scientists study these reactions are nicknamed “atom smashers,” not “atom coddlers.”
But gentle nuclear reactions represent more than a strange-sounding curiosity. These reactions let researchers stress-test certain scientific models that account for how the universe’s fundamental rules work, said Kaitlin Cook of the Facility for Rare Isotope Beams, or FRIB, at Michigan State University.
But gentle nuclear reactions represent more than a strange-sounding curiosity. These reactions let researchers stress-test certain scientific models that account for how the universe’s fundamental rules work, said Kaitlin Cook of the Facility for Rare Isotope Beams, or FRIB, at Michigan State University.
MSU Receives $6.7M Grant to Build Large Animal and Human Imaging Facility to Treat Diseases
Michigan State University has been awarded a National Institutes of Health $6.7 million grant to build a new facility to develop new imaging agents and treatments for diseases, including cancer, that afflict both humans and large animals.
"The new Large Animal Facility for Imaging and Image-guided Therapies will be one of the few such medical diagnostic facilities in the world," said project leader Anna Moore, assistant dean for the MSU College of Human Medicine and director of the Precision Health Program, adding: “This bridges our existing outstanding basic science and small animal imaging infrastructure, and our human imaging capabilities.”
"The new Large Animal Facility for Imaging and Image-guided Therapies will be one of the few such medical diagnostic facilities in the world," said project leader Anna Moore, assistant dean for the MSU College of Human Medicine and director of the Precision Health Program, adding: “This bridges our existing outstanding basic science and small animal imaging infrastructure, and our human imaging capabilities.”
Black Health Matters: Grant Funds Cancer Screening Equity
Colorectal cancer (CRC) is the third most common cancer type diagnosed in the United States in both men and women. The American Cancer Society estimates there will be nearly 150,000 new cases in 2021 and over 50,000 deaths. But CRC is preventable and very treatable if caught early. “Disparities in CRC screening have persisted in the African American community, but we have the tools to do something about it. If Black Lives Matter, then Black health should matter too,” Todd Lucas.
Testing a New Way to Tackle Cancer
Michigan State University, Spectrum Health and Lansing-based company Niowave have teamed up to develop a new strategy to fight cancer
A potential new weapon against cancer is entering the first phase of clinical trials thanks to a collaboration between Spectrum Health, the Lansing-based company Niowave and Michigan State University.
A potential new weapon against cancer is entering the first phase of clinical trials thanks to a collaboration between Spectrum Health, the Lansing-based company Niowave and Michigan State University.
Text Me About Cervical Cancer
An estimated 14,480 new cases of invasive cervical cancer will be diagnosed in the United States this year, according to the American Cancer Society. Cases that could be prevented or cured with better education from screening to treatment based on improved provider-patient communication, says a Michigan State University researcher.
The issue is particularly acute for Black women, said Sabrina Ford, an associate professor in the Department of Obstetrics, Gynecology and Reproductive Biology within MSU’s College of Human Medicine. Ford’s research was published online Feb. 1 in the journal Gynecologic Oncology.
The issue is particularly acute for Black women, said Sabrina Ford, an associate professor in the Department of Obstetrics, Gynecology and Reproductive Biology within MSU’s College of Human Medicine. Ford’s research was published online Feb. 1 in the journal Gynecologic Oncology.
MSU, Henry Ford Health System Finalize Partnership to Battle Health Disparities, Inequities
Henry Ford Health System and Michigan State University, two of the state’s leading education, research and health care institutions, are partnering to make Michigan a national leader in providing access to exceptional health care for all residents, scientific discovery and education for providers, patients and families.
In a landmark partnership that will last for at least 30 years, both institutions are committed to aligning efforts across key departments and programs to achieve critical health care and educational goals, while addressing social issues that impact health outcomes for patients in Michigan and beyond.
In a landmark partnership that will last for at least 30 years, both institutions are committed to aligning efforts across key departments and programs to achieve critical health care and educational goals, while addressing social issues that impact health outcomes for patients in Michigan and beyond.